Association of serum homocysteine with major depressive disorder: Results from a large population-based study

Psychoneuroendocrinology

Volumn 38, Issue 10, 2013, Pages 2309-2318

  Nabi, Hermann ^a,b   Bochud, Murielle ^c   Glaus, Jennifer ^d   Lasserre, Aurélie M ^d   Waeber, Gérard ^d   Vollenweider, Peter ^d   Preisig, Martin ^d  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Homocysteine; Major depressive disorder; Population based study

Indexed keywords

CHOLESTEROL; DIURETIC AGENT; HOMOCYSTEINE; TRIACYLGLYCEROL; VITAMIN;

ADULT; AGE; AGED; ALBUMINURIA; AMINO ACID BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG USE; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERTENSION; LIFESPAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBESITY; PHYSICAL INACTIVITY; PREVALENCE; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; RISK FACTOR; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; SINGLE (MARITAL STATUS); SMOKING;

HOMOCYSTEINE; MAJOR DEPRESSIVE DISORDER; POPULATION-BASED STUDY;

ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; SWITZERLAND;

EID: 84883859759     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.04.018     Document Type: Article

References (51)

1. Almeida O.P., Lautenschlager N., Flicker L., Leedman P., Vasikaran S., Gelavis A., Ludlow J. Association between homocysteine, depression, and cognitive function in community dwelling older women from Australia. J. Am. Geriatr. Soc. 2004, 52:327-328.
2. Almeida O.P., McCaul K., Hankey G.J., Norman P., Jamrozik K., Flicker L. Homocysteine and depression in later life. Arch. Gen. Psychiatry 2008, 65:1286-1294.
3. Bautista L.E., Arenas I.A., Penuela A., Martinez L.X. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J. Clin. Epidemiol. 2002, 55:882-887.
4. Bjelland I., Tell G.S., Vollset S.E., Refsum H., Ueland P.M. Folate, vitamin B12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch. Gen. Psychiatry 2003, 60:618-626.
5. Bonaa K.H., Njolstad I., Ueland P.M., Schirmer H., Tverdal A., Steigen T., Wang H., Nordrehaug J.E., Arnesen E., Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 2006, 354:1578-1588.
6. Bottiglieri T., Laundy M., Crellin R., Toone B.K., Carney M.W., Reynolds E.H. Homocysteine, folate, methylation, and monoamine metabolism in depression. J. Neurol. Neurosurg. Psychiatry 2000, 69:228-232.
7. Breslau N., Kilbey M.M., Andreski P. Nicotine dependence and major depression. New evidence from a prospective investigation. Arch. Gen. Psychiatry 1993, 50:31-35.
8. Byers A.L., Yaffe K., Covinsky K.E., Friedman M.B., Bruce M.L. High occurrence of mood and anxiety disorders among older adults: the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2010, 67:489-496.
9. Chellappa P., Ramaraj R. Depression, homocysteine concentration, and cardiovascular events. JAMA 2009, 301:1541-1542. author reply 1542.
10. Dimopoulos N., Piperi C., Salonicioti A., Psarra V., Gazi F., Papadimitriou A., Lea R.W., Kalofoutis A. Correlation of folate, vitamin B12 and homocysteine plasma levels with depression in an elderly Greek population. Clin. Biochem. 2007, 40:604-608.
11. Eaton W.W., Neufeld K., Chen L.S., Cai G. A comparison of self-report and clinical diagnostic interviews for depression: diagnostic interview schedule and schedules for clinical assessment in neuropsychiatry in the Baltimore epidemiologic catchment area follow-up. Arch. Gen. Psychiatry 2000, 57:217-222.
12. Firmann M., Mayor V., Vidal P.M., Bochud M., Pecoud A., Hayoz D., Paccaud F., Preisig M., Song K.S., Yuan X., Danoff T.M., Stirnadel H.A., Waterworth D., Mooser V., Waeber G., Vollenweider P. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc. Disord. 2008, 8:6.
13. Forti P., Rietti E., Pisacane N., Olivelli V., Dalmonte E., Mecocci P., Ravaglia G. Blood homocysteine and risk of depression in the elderly. Arch. Gerontol. Geriatr. 2010, 51:21-25.
14. Gol M., Akan P., Dogan E., Karas C., Saygili U., Posaci C. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels. Maturitas 2006, 53:252-259.
15. Hak A.E., Polderman K.H., Westendorp I.C., Jakobs C., Hofman A., Witteman J.C., Stehouwer C.D. Increased plasma homocysteine after menopause. Atherosclerosis 2000, 149:163-168.
16. Holmes M.V., Newcombe P., Hubacek J.A., Sofat R., Ricketts S.L., Cooper J., Breteler M.M., Bautista L.E., Sharma P., Whittaker J.C., Smeeth L., Fowkes F.G., Algra A., Shmeleva V., Szolnoki Z., Roest M., Linnebank M., Zacho J., Nalls M.A., Singleton A.B., Ferrucci L., Hardy J., Worrall B.B., Rich S.S., Matarin M., Norman P.E., Flicker L., Almeida O.P., van Bockxmeer F.M., Shimokata H., Khaw K.T., Wareham N.J., Bobak M., Sterne J.A., Smith G.D., Talmud P.J., van Duijn C., Humphries S.E., Price J.F., Ebrahim S., Lawlor D.A., Hankey G.J., Meschia J.F., Sandhu M.S., Hingorani A.D., Casas J.P. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 2011, 378:584-594.
17. Jacques P.F., Rosenberg I.H., Rogers G., Selhub J., Bowman B.A., Gunter E.W., Wright J.D., Johnson C.L. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 1999, 69:482-489.
18. Kamphuis M.H., Geerlings M.I., Grobbee D.E., Kromhout D. Dietary intake of B6-9-12 vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study. Eur. J. Clin. Nutr. 2007, 62:939-945.
19. Katon W.J., Lin E.H., Russo J., Von Korff M., Ciechanowski P., Simon G., Ludman E., Bush T., Young B. Cardiac risk factors in patients with diabetes mellitus and major depression. J. Gen. Intern. Med. 2004, 19:1192-1199.
20. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Yoon J.S. Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br. J. Psychiatry 2008, 192:268-274.
21. Leboyer M., Barbe B., Gorwood P., Teherani M., Allilaire J.F., Preisig M., Matthey M.L., Poyetton V., Ferrero F. Interview Diagnostique pour les Etudes Génétiques 1995, INSERM, Paris.
22. Lee M., Hong K.S., Chang S.C., Saver J.L. Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis. Stroke 2010, 41:1205-1212.
23. Lichtman J.H., Bigger J.T., Blumenthal J.A., Frasure-Smith N., Kaufmann P.G., Lesperance F., Mark D.B., Sheps D.S., Taylor C.B., Froelicher E.S. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008, 118:1768-1775.
24. Loprinzi P.D., Cardinal B.J. Interrelationships among physical activity, depression, homocysteine, and metabolic syndrome with special considerations by sex. Prev. Med. 2012, 54:388-392.
25. Malinow M.R., Bostom A.G., Krauss R.M. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999, 99:178-182.
26. Marti F., Vollenweider P., Marques-Vidal P.M., Mooser V., Waeber G., Paccaud F., Bochud M. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health 2011, 11:733.
27. Morris M.S., Fava M., Jacques P.F., Selhub J., Rosenberg I.H. Depression and folate status in the US population. Psychother. Psychosom. 2003, 72:80-87.
28. Muntjewerff J.W., Kahn R.S., Blom H.J., den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol. Psychiatry 2006, 11:143-149.
29. Myers J.K., Weissman M.M. Use of a self-report symptom scale to detect depression in a community sample. Am. J. Psychiatry 1980, 137:1081-1084.
30. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry 1994, 51:849-859. discussion 863-844.
31. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 1997, 337:230-236.
32. Pan A., Lucas M., Sun Q., van Dam R.M., Franco O.H., Manson J.E., Willett W.C., Ascherio A., Hu F.B. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch. Intern. Med. 2010, 170:1884-1891.
33. Pascoe M.C., Crewther S.G., Carey L.M., Noonan K., Crewther D.P., Linden T. Homocysteine as a potential biochemical marker for depression in elderly stroke survivors. Food Nutr. Res. 2012, 56.
34. Penninx B.W., Guralnik J.M., Ferrucci L., Fried L.P., Allen R.H., Stabler S.P. Vitamin B (12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am. J. Psychiatry 2000, 157:715.
35. Piccinelli M., Wilkinson G. Gender differences in depression. Critical review. Br. J. Psychiatry 2000, 177:486-492.
36. Preisig M., Fenton B.T., Matthey M.L., Berney A., Ferrero F. Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249:174-179.
37. Preisig M., Waeber G., Vollenweider P., Bovet P., Rothen S., Vandeleur C., Guex P., Middleton L., Waterworth D., Mooser V., Tozzi F., Muglia P. The PsyCoLaus study: methodology and characteristics of the sample of a population-based survey on psychiatric disorders and their association with genetic and cardiovascular risk factors. BMC Psychiatry 2009, 9:9.
38. Ramos M.I., Allen L.H., Haan M.N., Green R., Miller J.W. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am. J. Clin. Nutr. 2004, 80:1024.
39. Refsum H., Nurk E., Smith A.D., Ueland P.M., Gjesdal C.G., Bjelland I., Tverdal A., Tell G.S., Nygard O., Vollset S.E. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J. Nutr. 2006, 136:1731S-1740S.
40. Rubin R.R., Gaussoin S.A., Peyrot M., DiLillo V., Miller K., Wadden T.A., West D.S., Wing R.R., Knowler W.C. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia 2010, 53:1581-1589.
41. Sachdev P.S., Parslow R.A., Lux O., Salonikas C., Wen W., Naidoo D., Christensen H., Jorm A.F. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol. Med. 2005, 35:529-538.
42. Targher G., Bertolini L., Zenari L., Cacciatori V., Muggeo M., Faccini G., Zoppini G. Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care 2000, 23:524-528.
43. Tiemeier H., Tuijl H.R., Meijer J., Kiliaan A.J., Breteler M.M.B., Hofman A. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am. J. Psychiatry 2002, 159:2099-2101.
44. Tolmunen T., Hintikka J., Voutilainen S., Ruusunen A., Alfthan G., Nyyssonen K., Viinamaki H., Kaplan G.A., Salonen J.T. Association between depressive symptoms and serum concentrations of homocysteine in men: a population study. Am. J. Clin. Nutr. 2004, 80:1574-1578.
45. Ueland P.M., Refsum H., Stabler S.P., Malinow M.R., Andersson A., Allen R.H. Total homocysteine in plasma or serum: methods and clinical applications. Clin. Chem. 1993, 39:1764-1779.
46. Veeranna V., Zalawadiya S.K., Niraj A., Pradhan J., Ference B., Burack R.C., Jacob S., Afonso L. Homocysteine and reclassification of cardiovascular disease risk. J. Am. Coll. Cardiol. 2011, 58:1025-1033.
47. Vollset S.E., Refsum H., Tverdal A., Nygard O., Nordrehaug J.E., Tell G.S., Ueland P.M. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 2001, 74:130-136.
48. Walsh B.W., Paul S., Wild R.A., Dean R.A., Tracy R.P., Cox D.A., Anderson P.W. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J. Clin. Endocrinol. Metab. 2000, 85:214-218.
49. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 1998, 338:1042-1050.
50. Whooley M.A., de Jonge P., Vittinghoff E., Otte C., Moos R., Carney R.M., Ali S., Dowray S., Na B., Feldman M.D., Schiller N.B., Browner W.S. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008, 300:2379-2388.
51. Wouters M.G., Moorrees M.T., van der Mooren M.J., Blom H.J., Boers G.H., Schellekens L.A., Thomas C.M., Eskes T.K. Plasma homocysteine and menopausal status. Eur. J. Clin. Invest. 1995, 25:801-805.